| An engineered SARS-CoV-2 receptor-binding domain produced in Pichia pastoris as a candidate vaccine antigen M Limonta-Fernández, G Chinea-Santiago, AM Martín-Dunn, ... New Biotechnology 72, 11-21, 2022 | 40 | 2022 |
| In-solution buffer-free digestion allows full-sequence coverage and complete characterization of post-translational modifications of the receptor-binding domain of SARS-CoV-2 … LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, ... Analytical and Bioanalytical Chemistry 413 (30), 7559-7585, 2021 | 13 | 2021 |
| HeberNasvac, a therapeutic vaccine for chronic hepatitis b, stimulates local and systemic markers of innate immunity: Potential use in SARS-CoV-2 postexposure prophylaxis YA Fleites, J Aguiar, Z Cinza, M Bequet, E Marrero, M Vizcaíno, I Esquivel, ... Euroasian journal of hepato-gastroenterology 11 (2), 59, 2021 | 8 | 2021 |
| In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI … LA Espinosa, Y Ramos, I Andújar, EO Torres, G Cabrera, A Martín, ... BioRxiv, 2021.05. 10.443404, 2021 | 8 | 2021 |
| Nasalferon, a new nasal formulation of IFNα2b, modulates cellular and molecular elements associated with an antiviral response in mucosa and blood D Vázquez-Blomquist, M Bequet-Romero, Y Mendoza-Marí, G Lemos, ... Clinical Immunology Communications 2, 39-45, 2022 | 3 | 2022 |
| A combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial I Esquivel-Moynelo, J Pérez-Escribano, Y Duncan-Roberts, ... Ann Antivir Antiretrovir 5 (1), 001-014, 2021 | 3 | 2021 |
| Active immunization with a structurally aggregated PD-L1 antigen breaks T and B immune tolerance in non-human primates and exhibits in vivo anti-tumoral effects in … Y Morera-Díaz, C Canaán-Haden, J Sánchez-Ramírez, ... Cancer Letters 561, 216156, 2023 | 2 | 2023 |
| 19P Preclinical and clinical significance of VEGF deprivation in ovarian cancer through a specific active immunotherapy Y Morera, M Bequet-Romero, F Hernández-Bernal, I González-Moya, ... Annals of Oncology 34, S193, 2023 | | 2023 |
| 8P Modulating tumor microenvironment using a VEGF active immunotherapeutic approach in gastrointestinal tumors: Beyond angiogenesis modulation M Bequet-Romero, Y Morera, F Hernández-Bernal, C Canaan-Haden, ... Annals of Oncology 34, S189, 2023 | | 2023 |
| The SARS-CoV-2 receptor-binding domain expressed in Pichia pastoris as a candidate vaccine antigen (preprint) M Limonta-Fernández, G Chinea-Santiago, AM Martín-Dunn, ... | | 2021 |
Monica BequetSenior Researcher, Cancer Immunotherapy, Biomedical Research, CIGB, CUBAVerified email at cigb.edu.cu
